WAKA HPV Africa

Presentations

Presentations of the 7th WAKA meeting (Antwerp 2019)

The presentations included regional and international speakers, and focused on the following areas:

Open session 22nd November 2019

  • Tamrat Zeleke ABEBE: “Cervical Cancer control program in Ethiopia”
  • Andreas KAUFMANN: “Charité’s Challenges and Achievements in Cervical Cancer Screening in LMIC”
  • Hermann BUSSMANN: “Accelerating access to quality cervical cancer screening”
  • Matthys Hendrik BOTHA:

Presentations of the 6th WAKA meeting (Stellenbosch 2018)

The presentations included regional and international speakers, and focused on the following areas:

Open session 1st September 2018

  • Alex MUTOMBO: “”
  • Zacharie NDIZEYE: “HPV research in Burundi: which conclusions should we take”
  • Omenge ORANGO: “”
  • TiiTi Teboho: ""
  • Neil WOOD: “”
     
  • Suzette JORDAAN: “”
     
  • Matsontso MATHEBULA: “”
  • Mathilda MOGATHLE: “”
  • Carrie MINNAAR: “Electro-hyperthermia as a radiosensitiser for locally advanced HIV positive and negative cervical cancer patients”
  • Jo LISSENS: “Microbicides in screen and treat for cervical cancer ”

Presentations of the 4th WAKA meeting (Vereeniging 2016)

The presentations included regional and international speakers, and focused on the following areas:

SESSION 1: WORKSHOP QUALITY MANAGEMENT SYSTEMS

  1. Interactive workshop on quality management systems
    Kristien Van Brussel (UZA, Belgium)

SESSION 2: SASGO CONGRESS 2016

more information on their

SESSION 3 & 4: WAKA-HPV RESULTS


  1. John-Paul Bogers (UA, Belgium)

  2. Eshetu Lemma Haile (AAU, Ethiopia)

  3. Zacharie Ndizeye (UB, Burundi)

  4. Zacharie Ndizeye (UB, Burundi)

  5. Hillary Mabeya (MOI University, Kenia)

  6. Anayawa Nyambe (¶¶Òõ¶ÌÊÓƵ, Belgium)

  7. Antonella De Meyer (ILEX, South Africa)

  8. F. Matshonyonge (SMU, South Africa)

  9. Alex Mutombo Baleka (UNIKIN, DR Congo)
  10. Drug development, Indications and Projects
    Reiner van Tilborg (Cesa Alliance)

  11. John-Paul Bogers (UA, Belgium)

Presentations of the 3rd WAKA meeting (Kinshasa 2015)

The presentations included regional and international speakers, and focused on the following areas:

PREVENTION, SCREENING AND TREATMENT OF CERVICAL CANCER


  1. Dr Hillary MABEYA (MU, Kenya)

  2. Ms Anayawa NYAMBE (UA, Belgium)

  3. Dr. Raquel Inocêncio da Luz (UA/UNIKIN, DRCongo) and Dr Ngoy BAUMA (CESVI, Women Profile Africa)

  4. Dr Alex MUTOMBO (UNIKIN, DRCongo)

  5. Dr Joseph NGONZO (MUST, Uganda)

MOLECULAR TOOLS FOR HPV DETECTION


  1. Mr Eshetu HAILE (AAU, Ethiopia)

  2. Dr Lisbeth LEBELO (SMU, South Africa)

  3. Prof Pascal LUTUMBA (UNIKIN, DRCongo)

OTHER HPV RELATED INFECTIONS AND CANCERS


  1. Prof Erich RAUBENHEIMER (SMU, South Africa)

  2. Dr Cindy SIMOENS (UA, Belgium)

  3. Prof Neil WOOD (SMU, South Africa)

QUALITY CONTROL AND REFERENCE LABORATORIES, PROGRESS AND CHALLENGES IN AFRICA


  1. Kristien Van Brussel (UZA, Belgium)

  2. Prof N.M. BIDA (SMU, South Africa)

  3. Paulo GIOVENALI (APOF, Italy)

  4. Sergio ARNAUD (APOF, Italy)

Presentations of the 2nd WAKA meeting (Johannesburg 2015)

The research findings presented at the WAKA symposium in Johannesburg, South Africa (28-29 May 2015) included regional and international speakers, and focused on the following areas:

PROGRESS PhD STUDENTS


  1. Neil WOOD (SMU, South Africa)
  2. HPV prevalence in HIV infected population
    Zinhle MAKATINI (SMU, South Africa)
  3. Tampon like device for cervical cancer screening and HPV testing in South Africa
    Antonella DE MEYER (SMU, South Africa)
  4. Cervical cancer control in Burundi: Challenges
    Zacharie NDIZEYE (UB, Burundi)
  5. Molecular Epidemiology and Genetic Variability of Human Papillomavirus (HPV) In Adama, Oromiya, Ethiopia
    Eshetu HAILE (AAU, Ethiopia)
  6. In Search of the Optimal Cervical Cancer Prevention Measures for Zambia, using the SEM and TTI
    Anayawa NYAMBE (UA, Zambia-Belgium)
  7. HPV prevalence and cervical cancer screening in DRC
    Pascal LUTUMBA (UNIKIN, DR Congo)
  8. AV2, a key to cervical cancer prevention?
    Alex MUTOMBO (UNIKIN, DR Congo)
  9. HPV testing in Kenyan women
    Hillary Mirera MABEYA

HPV PROJECTS IN AFRICA


  1. Pascal LUTUMBA (UNIKIN, DR Congo)

  2. Andreas KAUFMANN

  3. Heather CUBIE

  4. Riaz SEEDAT (UFS, South Africa)

  5. Felicity BURT (UFS, South Africa)

CERVICAL CANCER SCREENING AND HPV TESTING

  1. Principles and applications of the Bio-Plex MAGPIX Multiplex Reader for magnetic bead-based immunoassays and oligonucleotide coupling
    Erica PIERCE (Bio-Rad, South Africa)
  2. HPV testing and dection on Aptima (Panther)
    Antonella DE MEYER (ILEX, South Africa)
  3. Experince with Luminex system for HPV genotyping
    Massimo TOMMASINO (IARC-WHO, France)
  4. Demonstration of cervical/vaginal sample collection (Thinprep)
    Hermant DU DOIT (SepSci, South Africa)
  5. Protein based HPV/ Cervical Screen Point of Care System
    Peter GOMBRICH (Oncogenesis, USA)

SETTING UP INTERNATIONAL TRAINING REFERENCE LABORATORY

  1. Establishing and maintaning a reference training centre in a district hospital
    Andreas KAUFMANN
  2. Logistics and resources to set up international reference and training laboratory
    Heather CUBIE
  3. Progress on HPV reference laboratory at SMU
    Lisbeth LEBELO & John-Paul BOGERS

Presentations of the 1st WAKA meeting (Pretoria 2014)

The research findings presented at the WAKA symposium in Pretoria, South Africa (22-23 May 2014) included regional and international speakers, and focused on the following areas:

INTRODUCTION

  1. Cervical Cancer and Control Strategies
    Jean-Pierre Van geertruyden (UA, Belgium)
  2. Other HPV related cancers and update on HPV vaccines
    John-Paul Bogers (UA, Belgium)

HPV BURDEN OF DISEASE AND EPIDEMIOLOGY

  1. Cervical cancer screening: Pathologist’s Perspective
    Meshack BIDA (SMU, South Africa)
  2. HPV associated head and neck cancers and lesions
    Eric RAUBENHEIMER (SMU, South Africa)
  3. Management of cervical cancer in HIV positive women
    Thebeni MSIBI (SMU, South Africa)
  4. HPV types in anal carcinomas at Dr George Mukhari Academic Hospital, Pretoria
    Nokulunga DLAMINI (SMU, South Africa)
  5. HPV types in cancerous and pre-cancerous penile lesions of South African men
    Lisbeth LEBELO (SMU, South Africa)

HPV BURDEN OF DISEASE AND EPIDEMIOLOGY

  1. The perceptions and  viewpoints of policymakers and Zambian people on Cervical Cancer
    Anayawa NYAMBE (UA, Zambia)
  2. HPV Burden of Disease and Epidemiology: Experience from Uganda
    Joseph NGONZI (MUST, Uganda)
  3. HPV Burden of Disease and Epidemiology: Experience from Ethiopia
    Hailemariam ABAWOLLO (Jimma University, Ethiopia)
  4. HPV Burden of Disease and Epidemiology: Experience from Kenya
    Davy Vanden Broeck (MOI, Kenya)

LABORATORY CAPACITY IN AFRICA

  1. HPV Burden of Disease and Epidemiology: Experience from Burundi
    Zacharie NDIZEYE (University of Burundi)
  2. HPV Burden of Disease and Epidemiology: Experience from Congo
    Alex MUTOMBO (University of Kinshasa)
  3. Overview of HPV detection and typing methods
    Ina BENOY (UA, Belgium)
  4. HPV detection and typing in biopsied tissues
    Lisbeth LEBELO (SMU, South Africa)
  5. HPV detection and typing: Experience from Congo
    Rhama TOZIN (UNIKIN, DR Congo)
  6. Epidemiology of HPV and evaluation of clinical performance of via, Pap and HPV DNA tests and cervical cancer specimens collection techniques in Ethiopia
    Eshetu HAILE (Addis Ababa University, Ethiopia)
  7. The role of pathology laboratory: cytology and histology
    Tennyson LEKALAKALA (SMU, South Africa)